tiprankstipranks
Trending News
More News >
Cue Biopharma (CUE)
:CUE
US Market
Advertisement

Cue Biopharma (CUE) Technical Analysis

Compare
611 Followers

Technical Sentiment

Overall Consensus
Buy
13Bullish
6Neutral
3Bearish
Technical Analysis Consensus
Buy
3Bullish
6Neutral
1Bearish
Moving Average Consensus
Strong Buy
10Bullish
0Neutral
2Bearish
Cue Biopharma’s (CUE) Moving Averages Convergence Divergence (MACD) indicator is <0.01, suggesting Cue Biopharma is a Buy.
Cue Biopharma’s (CUE) 20-Day exponential moving average is 0.81, while Cue Biopharma’s (CUE) share price is $0.83, making it a Buy.
Cue Biopharma’s (CUE) 50-Day exponential moving average is 0.79, while Cue Biopharma’s (CUE) share price is $0.83, making it a Buy.

Cue Biopharma (CUE) Pivot Points

Aug 17, 2025, 03:18 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.73
0.76
0.77
0.80
0.81
0.84
0.85
Fibonacci
0.76
0.77
0.78
0.80
0.81
0.82
0.84
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Cue Biopharma (CUE) Moving Averages

Aug 17, 2025, 03:18 PM
Period
Simple
Exponential
MA5
0.81Buy
0.81Buy
MA10
0.81Buy
0.81Buy
MA20
0.82Buy
0.81Buy
MA50
0.75Buy
0.79Buy
MA100
0.75Buy
0.82Buy
MA200
1.01Sell
0.93Sell
Cue Biopharma’s (CUE) 10-Day exponential moving average is 0.81, while Cue Biopharma’s (CUE) share price is $0.83, making it a Buy.
Cue Biopharma’s (CUE) 100-Day exponential moving average is 0.82, while Cue Biopharma’s (CUE) share price is $0.83, making it a Buy.
Cue Biopharma’s (CUE) stock price is $0.83 and Cue Biopharma’s (CUE) 50-day simple moving average is 0.75, creating a Buy signal.
Cue Biopharma’s (CUE) stock price is $0.83 and Cue Biopharma’s (CUE) 100-day simple moving average is 0.75, creating a Buy signal.
Cue Biopharma’s (CUE) stock price is $0.83 and Cue Biopharma’s (CUE) 200-day simple moving average is 1.01, creating a Sell signal.

Cue Biopharma (CUE) Technical Indicators

Aug 17, 2025, 03:18 PM
Name
Value
Implied Action
RSI (14)
53.87
Neutral
STOCH (9,6)
62.42
Neutral
STOCHRSI (14)
51.65
Neutral
MACD (12,26)
<0.01
Buy
ADX (14)
29.87
Neutral
Williams %R
-36.08
Buy
CCI (14)
-30.98
Neutral
ATR (14)
0.08
-
Ultimate Oscillator
53.57
Neutral
ROC
1.22
Buy
Cue Biopharma’s (CUE) Relative Strength Index (RSI) is 53.87, creating a Neutral signal.
Cue Biopharma’s (CUE) Trend Strength Indicator (ADX) is 29.87, creating a Neutral signal.
Cue Biopharma’s (CUE) Commodity Channel Index (CCI) is -30.98, creating a Neutral signal.
Cue Biopharma’s (CUE) Price Rate of Change (ROC) is 1.22, creating a Buy signal.

FAQ

Is CUE a Buy, Hold, or Sell?
Based on CUE’s technical indicators, CUE is a Buy.
    What is CUE’s RSI (14)?
    CUE’s RSI (14) is 53.87, which suggests CUE is a Neutral.
      What is CUE’s MACD?
      CUE’s MACD is <0.01, which suggests CUE is a Buy.
        What is CUE’s 5-day moving average?
        CUE’s 5-day moving average is 0.81, which suggests CUE is a Buy.
          What is CUE’s 20-day moving average?
          CUE 20-day moving average is 0.82, which suggests CUE is a Buy.
            What is CUE’s 50-day moving average?
            CUE’s 50-day moving average is 0.75, which suggests CUE is a Buy.
              What is CUE’s 200-day moving average?
              CUE’s 200-day moving average is 1.01, which suggests CUE is a Sell.
                What is CUE’s Williams % R (14)?
                CUE’s Williams % R (14) is -36.08, which suggests CUE is a Buy.
                  What is CUE’s CCI (14)?
                  CUE’s CCI (14) is -30.98, which suggests CUE is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis